Hangzhou Sumgen Biotech Co., Ltd.
Clinical trials sponsored by Hangzhou Sumgen Biotech Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug targets Hard-to-Treat cancers by homing in on a specific protein Results expected Feb 2027 (estimated)
- Can a new infusion stop the Body's attack on a transplanted kidney? Results expected Mar 2027 (estimated)
- New antibody combo aims to stall multiple Myeloma's return Results expected Mar 2027 (estimated)
- Experimental injection aims to boost platelets in chronic blood disorder Results expected May 2027 (estimated)